AIDS Drug Assistance Programs (ADAPs), authorized under the Ryan White Program, are the nations prescription drug safety-net for people living with HIV, serving some of the most vulnerable people in the U.S. The 2009 report presents the most current and comprehensive look at these programs, including key trends over time, challenges facing ADAPs, and the reemergence of waiting lists for enrollment in some states. An expert panel discusses the changing environment for ADAPs, including a look at the impact that the nations recession is having on the programs and their clients.
All Comments